These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18382143)

  • 1. Stabilization of measles virus for vaccine formulation.
    Kissmann J; Ausar SF; Rudolph A; Braun C; Cape SP; Sievers RE; Federspiel MJ; Joshi SB; Middaugh CR
    Hum Vaccin; 2008; 4(5):350-9. PubMed ID: 18382143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards ambient temperature-stable vaccines: the identification of thermally stabilizing liquid formulations for measles virus using an innovative high-throughput infectivity assay.
    Schlehuber LD; McFadyen IJ; Shu Y; Carignan J; Duprex WP; Forsyth WR; Ho JH; Kitsos CM; Lee GY; Levinson DA; Lucier SC; Moore CB; Nguyen NT; Ramos J; Weinstock BA; Zhang J; Monagle JA; Gardner CR; Alvarez JC
    Vaccine; 2011 Jul; 29(31):5031-9. PubMed ID: 21616113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards development of stable formulations of a live attenuated bacterial vaccine: a preformulation study facilitated by a biophysical approach.
    Zeng Y; Fan H; Chiueh G; Pham B; Martin R; Lechuga-Ballesteros D; Truong VL; Joshi SB; Middaugh CR
    Hum Vaccin; 2009 May; 5(5):322-31. PubMed ID: 19221516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stabilizing formulations for inhalable powders of live-attenuated measles virus vaccine.
    Burger JL; Cape SP; Braun CS; McAdams DH; Best JA; Bhagwat P; Pathak P; Rebits LG; Sievers RE
    J Aerosol Med Pulm Drug Deliv; 2008 Mar; 21(1):25-34. PubMed ID: 18518829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biophysical characterization of rotavirus serotypes G1, G3 and G4.
    Esfandiary R; Yee L; Ohtake S; Martin RA; Truong-Le VL; Lechuga-Ballesteros D; Moore DS; Joshi SB; Middaugh CR
    Hum Vaccin; 2010 May; 6(5):390-8. PubMed ID: 20534978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of a More Immunogenic Measles Vaccine by Increasing Its Hemagglutinin Expression.
    Julik E; Reyes-Del Valle J
    J Virol; 2016 Jun; 90(11):5270-5279. PubMed ID: 26984727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the thermal stability of live-attenuated Rubella vaccine (Takahashi strain) formulated and lyophilized in different stabilizers.
    Shokri S; Shahkarami MK; Shafyi A; Mohammadi A; Esna-Ashari F; Hamta A
    J Virol Methods; 2019 Feb; 264():18-22. PubMed ID: 30144493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation Development and Improved Stability of a Combination Measles and Rubella Live-Viral Vaccine Dried for Use in the Nanopatch
    Wan Y; Gupta V; Bird C; Pullagurla SR; Fahey P; Forster A; Volkin DB; Joshi SB
    Hum Vaccin Immunother; 2021 Aug; 17(8):2501-2516. PubMed ID: 33957843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A powder formulation of measles vaccine for aerosol delivery.
    LiCalsi C; Maniaci MJ; Christensen T; Phillips E; Ward GH; Witham C
    Vaccine; 2001 Mar; 19(17-19):2629-36. PubMed ID: 11257402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. H1N1 influenza virus-like particles: physical degradation pathways and identification of stabilizers.
    Kissmann J; Joshi SB; Haynes JR; Dokken L; Richardson C; Middaugh CR
    J Pharm Sci; 2011 Feb; 100(2):634-45. PubMed ID: 20669328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heat-stable measles vaccine produced by spray drying.
    Ohtake S; Martin RA; Yee L; Chen D; Kristensen DD; Lechuga-Ballesteros D; Truong-Le V
    Vaccine; 2010 Feb; 28(5):1275-84. PubMed ID: 19944152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measles virus.
    Naim HY
    Hum Vaccin Immunother; 2015; 11(1):21-6. PubMed ID: 25483511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic approach toward stabilization of CagL, a protein antigen from Helicobacter pylori that is a candidate subunit vaccine.
    Choudhari SP; Pendleton KP; Ramsey JD; Blanchard TG; Picking WD
    J Pharm Sci; 2013 Aug; 102(8):2508-19. PubMed ID: 23794457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation design and high-throughput excipient selection based on structural integrity and conformational stability of dilute and highly concentrated IgG1 monoclonal antibody solutions.
    Bhambhani A; Kissmann JM; Joshi SB; Volkin DB; Kashi RS; Middaugh CR
    J Pharm Sci; 2012 Mar; 101(3):1120-35. PubMed ID: 22147527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined semi-empirical screening and design of experiments (DOE) approach to identify candidate formulations of a lyophilized live attenuated tetravalent viral vaccine candidate.
    Patel A; Erb SM; Strange L; Shukla RS; Kumru OS; Smith L; Nelson P; Joshi SB; Livengood JA; Volkin DB
    Vaccine; 2018 May; 36(22):3169-3179. PubMed ID: 28506515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of an oncolytic herpes simplex virus drug candidate.
    Kumru OS; Joshi SB; Thapa P; Pheasey N; Bullock PS; Bashiri H; Siska CS; Kerwin BA; He F; Volkin DB; Middaugh CR
    J Pharm Sci; 2015 Feb; 104(2):485-94. PubMed ID: 25362835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Live-attenuated measles virus vaccine targets dendritic cells and macrophages in muscle of nonhuman primates.
    Rennick LJ; de Vries RD; Carsillo TJ; Lemon K; van Amerongen G; Ludlow M; Nguyen DT; Yüksel S; Verburgh RJ; Haddock P; McQuaid S; Duprex WP; de Swart RL
    J Virol; 2015 Feb; 89(4):2192-200. PubMed ID: 25473055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation development of a plant-derived H1N1 influenza vaccine containing purified recombinant hemagglutinin antigen.
    Iyer V; Liyanage MR; Shoji Y; Chichester JA; Jones RM; Yusibov V; Joshi SB; Middaugh CR
    Hum Vaccin Immunother; 2012 Apr; 8(4):453-64. PubMed ID: 22370514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of vaccine stability.
    Volkin DB; Burke CJ; Sanyal G; Middaugh CR
    Dev Biol Stand; 1996; 87():135-42. PubMed ID: 8854010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine instability in the cold chain: mechanisms, analysis and formulation strategies.
    Kumru OS; Joshi SB; Smith DE; Middaugh CR; Prusik T; Volkin DB
    Biologicals; 2014 Sep; 42(5):237-59. PubMed ID: 24996452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.